| Category: Equity: Sectoral-Pharma and Healthcare |
| Launch Date: 05-07-2019 |
| Asset Class: Equity |
| Benchmark: BSE Healthcare TRI |
| TER: 2.27% As on (30-04-2026) |
| Status: Open Ended Schemes |
| Minimum Investment: 1000.0 |
| Minimum Topup: 1000.0 |
| Total Assets: 900.87 Cr As on 30-04-2026(Source:AMFI) |
| Turn over: 0.26% | Exit Load: For redemption/switch-out of units on or before 30 days from the date of allotment: 1.00% of applicable NAV. For redemption/switch-out of units after 30 days from the date of allotment: Nil |
Time it would have taken to make your money double (2x), quadruple (4x) and quintuple (5x)
The scheme provides long term capital appreciation by investing in equity/equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India. The Scheme does not guarantee/indicate any returns. There can be no assurance that the schemes’ objectives will be achieved.
| Standard Deviation | 16.16 |
| Sharpe Ratio | 1.07 |
| Alpha | 1.67 |
| Beta | 0.91 |
| Yield to Maturity | - |
| Average Maturity | - |
| Scheme Name | Inception Date |
1 Year Return(%) |
2 Year Return(%) |
3 Year Return(%) |
5 Year Return(%) |
10 Year Return(%) |
|---|---|---|---|---|---|---|
| Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth | 05-07-2019 | 10.58 | 10.96 | 23.17 | 12.39 | - |
Minimum investment in equity & equity related instruments of a particular sector/ particular theme - 80% of total assets.
Small Cap
34.05%
Others
1.39%
Large Cap
40.41%
Mid Cap
24.15%